182

Bispecific antibodies – a novel tool for anti-allergic therapy

Prof. Levi-Schaffer Francesca, HUJI, School of Medicine - IMRIC, School of Pharmacy- Institute for Drug Research

Additional material on the technology can be supplied upon request

Patent Status

Granted US 8,133,485

Contact for more information:

Ariela Markel
VP, Business Development, Healthcare
+972-2-6586608